US2015231205A1PendingUtilityA1
Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with annexin a1 short peptide
Est. expiryOct 16, 2029(~3.2 yrs left)· nominal 20-yr term from priority
C07K 5/1019A61K 38/1709C07K 7/06C07K 14/47A61K 38/07A61K 38/08A61P 9/10
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method of treating, ameliorating or preventing myocardial ischemia/reperfusion injury in a subject in need thereof, by administering to the subject a therapeutically effective amount of an ANXA1short peptide (ANXA1sp).
Claims
exact text as granted — not AI-modified1 . A method of treating myocardial ischemia/reperfusion injury in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of an ANXA1 short peptide (ANXA1sp).
2 . A method of ameliorating myocardial ischemia/reperfusion injury in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of an ANXA1 sp.
3 . (canceled)
4 . The method of claim 1 , wherein the myocardial ischemia/reperfusion injury is perioperative.
5 . The method of claim 1 , wherein the subject is normoglycemic.
6 . The method of claim 1 , wherein the subject is hyperglycemic.
7 . A kit for the treatment, amelioration or prevention of myocardial ischemia/reperfusion injury in a subject in need thereof, comprising an ANXA1sp and instructions for use in the treatment, amelioration or prevention of myocardial ischemia/reperfusion injury in a subject in need thereof.
8 . The kit of claim 7 , wherein the myocardial ischemia/reperfusion injury is perioperative.
9 - 15 . (canceled)Join the waitlist — get patent alerts
Track US2015231205A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.